Citation Impact
Citing Papers
Treatment Response Assessment in IDH-Mutant Glioma Patients by Noninvasive 3D Functional Spectroscopic Mapping of 2-Hydroxyglutarate
2015 StandoutNobel
Phase I/IIa Study of Cilengitide and Temozolomide With Concomitant Radiotherapy Followed by Cilengitide and Temozolomide Maintenance Therapy in Patients With Newly Diagnosed Glioblastoma
2010
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
2012 Standout
A preliminary quantitative proteomic analysis of glioblastoma pseudoprogression
2015
Proteomic dataset for altered glycoprotein expression upon GALNT3 knockdown in ovarian cancer cells
2016 StandoutNobel
Response Assessment Criteria for Glioblastoma: Practical Adaptation and Implementation in Clinical Trials of Antiangiogenic Therapy
2013
Nasopharyngeal carcinoma
2005 Standout
Efficient multi-scale 3D CNN with fully connected CRF for accurate brain lesion segmentation
2016 Standout
A single-arm phase II Austrian/German multicenter trial on continuous daily sunitinib in primary glioblastoma at first recurrence (SURGE 01-07)
2013
A Novel Method for Volumetric MRI Response Assessment of Enhancing Brain Tumors
2011
CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014
2017 Standout
Local therapy in localized Ewing tumors: results of 1058 patients treated in the CESS 81, CESS 86, and EICESS 92 trials
2002
Gene Therapy-Mediated Reprogramming Tumor Infiltrating T Cells Using IL-2 and Inhibiting NF-κB Signaling Improves the Efficacy of Immunotherapy in a Brain Cancer Model
2012 StandoutNobel
Incidence of early pseudo‐progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide
2008
Integrins in cancer: biological implications and therapeutic opportunities
2009 Standout
Treatment planning and delivery of intensity-modulated radiation therapy for primary nasopharynx cancer
2001
A survey of MRI-based medical image analysis for brain tumor studies
2013 Standout
Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099.
1998 Standout
Timing of Chemoradiotherapy and Patient Selection for Locally Advanced Nasopharyngeal Carcinoma
2003
Tumour-infiltrating CD4+ and CD8+ lymphocytes as predictors of clinical outcome in glioma
2014
Glioblastoma and Other Malignant Gliomas
2013 Standout
Phase II trial of pre-irradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: long term results of RTOG BR0131
2015
Increased sensitivity to radiochemotherapy in IDH1 mutant glioblastoma as demonstrated by serial quantitative MR volumetry
2013
Die Therapie der primären kutanen B-Zell-Lymphome
2000
Personalized treatment strategies in glioblastoma: MGMT promoter methylation status
2013
WHO-EORTC classification for cutaneous lymphomas
2005 Standout
CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma
2002 Standout
Soft-Tissue Sarcomas in Adults
2005 Standout
TFOS DEWS II pathophysiology report
2017 Standout
Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
2014 Standout
3D Slicer as an image computing platform for the Quantitative Imaging Network
2012 Standout
Initial experience with bevacizumab treatment for biopsy confirmed cerebral radiation necrosis
2009
The Global DNA Methylation Surrogate LINE-1 Methylation Is Correlated with MGMT Promoter Methylation and Is a Better Prognostic Factor for Glioma
2011
Advanced MRI and PET imaging for assessment of treatment response in patients with gliomas
2010
Orbital lymphoma: radiotherapy outcome and complications
2001
Immunotherapy response assessment in neuro-oncology: a report of the RANO working group
2015
Neurological adverse effects caused by cytotoxic and targeted therapies
2009
MGMT Promoter Methylation and Glioblastoma Prognosis: A Systematic Review and Meta-analysis
2013
Advanced imaging techniques in brain tumors
2009
Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience
2002 Standout
Glioblastoma: pathology, molecular mechanisms and markers
2015
Sickle-cell disease
2010 Standout
Pseudoprogression and pseudoresponse: Challenges in brain tumor imaging
2009
Carcinoma of the nasopharynx treated by radiotherapy alone: Determinants of local and regional control
1997
Microtubule-binding agents: a dynamic field of cancer therapeutics
2010 Standout
A metabolic labeling approach for glycoproteomic analysis reveals altered glycoprotein expression upon GALNT3 knockdown in ovarian cancer cells
2016 StandoutNobel
Clinical activity and safety of atezolizumab in patients with recurrent glioblastoma
2018
Primary brain tumours in adults
2012 Standout
EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT
2011
Prognostic and predictive value of epigenetic silencing of MGMT in patients with high grade gliomas: a systematic review and meta-analysis
2011
Cornerstones of CRISPR–Cas in drug discovery and therapy
2016 StandoutNobel
Multicentre phase II studies evaluating imatinib plus hydroxyurea in patients with progressive glioblastoma
2009
High-grade malignant glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010
Radiomics: the bridge between medical imaging and personalized medicine
2017 Standout
The sequential use of carmustine wafers (Gliadel®) and post-operative radiotherapy with concomitant temozolomide followed by adjuvant temozolomide: a clinical review
2011
Survival of Patients with Newly Diagnosed Glioblastoma Treated with Radiation and Temozolomide in Research Studies in the United States
2010
Nasopharyngeal carcinoma: Result of treatment with cis-diamminedichloroplatinum II, 5 fluorouracil, and radiation therapy
1988
Hypofractionated stereotactic radiation therapy for recurrent glioblastoma: single institutional experience
2013
Management of glioblastoma: State of the art and future directions
2020 Standout
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011–2015
2018 Standout
Single Center Experience of a New Intensive Induction Therapy for Ewing’s Family of Tumors: Feasibility, Toxicity, and Stem Cell Mobilization Properties
2003
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout
The epidemiology of glioma in adults: a "state of the science" review
2014 Standout
End Point Assessment in Gliomas: Novel Treatments Limit Usefulness of Classical Macdonald's Criteria
2009
Artificial intelligence in cancer imaging: Clinical challenges and applications
2019 Standout
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014–2018
2021 Standout
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012–2016
2019 Standout
Facile bio-synthesis of gold nanoparticles by using extract of Hibiscus sabdariffa and evaluation of its cytotoxicity against U87 glioblastoma cells under hyperglycemic condition
2015 Standout
Treatment and Clinical Management of Primary Mediastinal Large B-Cell Lymphoma With Sclerosis: MACOP-B Regimen and Mediastinal Radiotherapy Monitored by 67Gallium Scan in 50 Patients
1999
Association Between Hyperglycemia and Survival in Patients With Newly Diagnosed Glioblastoma
2009
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
2010 Standout
Epidemiologic and Molecular Prognostic Review of Glioblastoma
2014 Standout
Long-Term Event-Free Survival After Intensive Chemotherapy for Ewing’s Family of Tumors in Children and Young Adults
2003
Works of G. Frezza being referenced
Nongastrointestinal mucosa-associated lymphoid tissue (MALT) lymphomas: Clinical and therapeutic features of 24 localized patients
1997
Primary Gastric Lymphoma: A Clinical and Therapeutic Evaluation of 82 Patients
1995
Disease progression or pseudoprogression after concomitant radiochemotherapy treatment: Pitfalls in neurooncology
2008
Primary Mediastinal B-Cell Lymphoma with Sclerosis: Clinical and Therapeutic Evaluation of 22 Patients
1996
Italian Cooperative Study for the treatment of children and young adults with localized Ewing sarcoma of bone
1999
Localized orbital lymphoma.
1997
MGMT Promoter Methylation Status Can Predict the Incidence and Outcome of Pseudoprogression After Concomitant Radiochemotherapy in Newly Diagnosed Glioblastoma Patients
2008
Patterns of failure in nasopharyngeal cancer treated with megavoltage irradiation
1986
Recurrence Pattern After Temozolomide Concomitant With and Adjuvant to Radiotherapy in Newly Diagnosed Patients With Glioblastoma: Correlation With MGMT Promoter Methylation Status
2009